The Food and Drug Administration Friday warned physicians and patients who use medical devices to monitor levels of the blood thinner warfarin that certain test strips used with the devices may provide inaccurate results and should not be relied on to adjust the drug dosage. The CoaguChek XS PT Test Strips were manufactured by Roche and distributed by Terrific Care/Medex Supply. They include catalog numbers for test strips that were excluded from a recent Roche recall because they were not labeled or authorized for sale in the U.S. However, Terrific Care/Medex Supply purchased the Roche test strips from an unknown source and imported and sold them in the U.S., FDA said. “Monitoring warfarin dosing is a critical part of using the drug properly to prevent and treat blood clots,” said FDA Commissioner Scott Gottlieb, M.D. “Using faulty strips can lead to errors in medication dosage that could cause serious harm or death in some patients. That’s why it’s so concerning that this distributor continued to sell these test strips in the U.S. even though domestic sales had been stopped due to safety concerns.”

Related News Articles

Headline
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Headline
Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a…
Headline
The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranier’s Rx Laboratory Inc. from manufacturing or…
Headline
The Healthcare and Public Health Sector Coordinating Council (HSCC) today released a consensus-based guide to developing, deploying and supporting cyber-secure…
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
Early results from studies to better understand how duodenoscopes are reprocessed in real-world settings have found higher than expected contamination rates…